GJB2
This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq]
Full Name
gap junction protein, beta 2, 26kDa
Function
Structural component of gap junctions (PubMed:17551008, PubMed:19340074, PubMed:21094651, PubMed:26753910, PubMed:16849369, PubMed:19384972).
Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane (PubMed:17551008, PubMed:19340074, PubMed:21094651, PubMed:26753910).
Small molecules and ions diffuse from one cell to a neighboring cell via the central pore (PubMed:21094651, PubMed:16849369, PubMed:19384972).
Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane (PubMed:17551008, PubMed:19340074, PubMed:21094651, PubMed:26753910).
Small molecules and ions diffuse from one cell to a neighboring cell via the central pore (PubMed:21094651, PubMed:16849369, PubMed:19384972).
Biological Process
Aging Source: Ensembl
Cell-cell signaling Source: UniProtKB
Cellular response to dexamethasone stimulus Source: Ensembl
Cellular response to glucagon stimulus Source: Ensembl
Cellular response to oxidative stress Source: Ensembl
Decidualization Source: Ensembl
Epididymis development Source: Ensembl
Gap junction assembly Source: ARUK-UCL
Gap junction-mediated intercellular transport Source: UniProtKB
Inner ear development Source: Ensembl
Response to antibiotic Source: Ensembl
Response to estradiol Source: Ensembl
Response to human chorionic gonadotropin Source: Ensembl
Response to ischemia Source: Ensembl
Response to lipopolysaccharide Source: Ensembl
Response to progesterone Source: Ensembl
Response to retinoic acid Source: Ensembl
Sensory perception of sound Source: UniProtKB-KW
Transmembrane transport Source: ARUK-UCL
Cell-cell signaling Source: UniProtKB
Cellular response to dexamethasone stimulus Source: Ensembl
Cellular response to glucagon stimulus Source: Ensembl
Cellular response to oxidative stress Source: Ensembl
Decidualization Source: Ensembl
Epididymis development Source: Ensembl
Gap junction assembly Source: ARUK-UCL
Gap junction-mediated intercellular transport Source: UniProtKB
Inner ear development Source: Ensembl
Response to antibiotic Source: Ensembl
Response to estradiol Source: Ensembl
Response to human chorionic gonadotropin Source: Ensembl
Response to ischemia Source: Ensembl
Response to lipopolysaccharide Source: Ensembl
Response to progesterone Source: Ensembl
Response to retinoic acid Source: Ensembl
Sensory perception of sound Source: UniProtKB-KW
Transmembrane transport Source: ARUK-UCL
Cellular Location
Cell membrane; Gap junction. Colocalizes with GJB4 at gap junction plaques in the cochlea.
Involvement in disease
Deafness, autosomal recessive, 1A (DFNB1A):
A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.
Deafness, autosomal dominant, 3A (DFNA3A):
A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.
Vohwinkel syndrome (VOWNKL):
An autosomal dominant disease characterized by hyperkeratosis, constriction on fingers and toes and congenital deafness.
Keratoderma, palmoplantar, with deafness (PPKDFN):
An autosomal dominant disorder characterized by the association of palmoplantar hyperkeratosis with progressive, bilateral, high-frequency, sensorineural deafness.
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD):
An autosomal dominant form of keratitis-ichthyosis-deafness syndrome, a disease characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. Clinical features include deafness, ichthyosis, photophobia, absent or decreased eyebrows, sparse or absent scalp hair, decreased sweating and dysplastic finger and toenails.
Bart-Pumphrey syndrome (BAPS):
An autosomal dominant disorder characterized by sensorineural hearing loss, palmoplantar keratoderma, knuckle pads, and leukonychia, It shows considerable phenotypic variability.
Ichthyosis hystrix-like with deafness syndrome (HID syndrome):
An autosomal dominant keratinizing disorder characterized by sensorineural deafness and spiky hyperkeratosis affecting the entire skin. HID syndrome is considered to differ from the similar KID syndrome in the extent and time of occurrence of skin symptoms and the severity of the associated keratitis.
A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.
Deafness, autosomal dominant, 3A (DFNA3A):
A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.
Vohwinkel syndrome (VOWNKL):
An autosomal dominant disease characterized by hyperkeratosis, constriction on fingers and toes and congenital deafness.
Keratoderma, palmoplantar, with deafness (PPKDFN):
An autosomal dominant disorder characterized by the association of palmoplantar hyperkeratosis with progressive, bilateral, high-frequency, sensorineural deafness.
Keratitis-ichthyosis-deafness syndrome, autosomal dominant (KIDAD):
An autosomal dominant form of keratitis-ichthyosis-deafness syndrome, a disease characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. Clinical features include deafness, ichthyosis, photophobia, absent or decreased eyebrows, sparse or absent scalp hair, decreased sweating and dysplastic finger and toenails.
Bart-Pumphrey syndrome (BAPS):
An autosomal dominant disorder characterized by sensorineural hearing loss, palmoplantar keratoderma, knuckle pads, and leukonychia, It shows considerable phenotypic variability.
Ichthyosis hystrix-like with deafness syndrome (HID syndrome):
An autosomal dominant keratinizing disorder characterized by sensorineural deafness and spiky hyperkeratosis affecting the entire skin. HID syndrome is considered to differ from the similar KID syndrome in the extent and time of occurrence of skin symptoms and the severity of the associated keratitis.
View more
Anti-GJB2 antibodies
+ Filters
Loading...
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Mouse, Rat
Clone: CBWJC-3729
Application*: E, C, IH, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Human, Mouse, Rat
Clone: CBWJC-3728
Application*: E, IF, C, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgM, κ
Specificity: Human, Mouse, Sheep, Rat
Clone: CBWJC-3727
Application*: E, IC, IF, IP, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBXC-1713
Application*: WB, IP, E
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Mouse, Rat
Clone: CBYY-C3157
Application*: E, IH, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: CBFYC-2722
Application*: E, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Mouse, Rat
Clone: 3G101
Application*: E, C, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Rat
Clone: CBFYH-3440
Application*: E, IH, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Mouse
Clone: CBFYH-3367
Application*: E, IH, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Rat
Clone: CBLG1-1203
Application*: E, C, P, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Mouse
Clone: CBLG1-1202
Application*: E, IF, P, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Rat
Clone: CX-12H10
Application*: E, C, P, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: 1C6
Application*: E, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG1, κ
Specificity: Rat
Clone: CBLG1-109
Application*: E, IH, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Mouse
Clone: CBLG1-108
Application*: E, IH, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2b, κ
Specificity: Human
Clone: CBFYH-0365
Application*: E, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: 5F3
Application*: IH, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: 1E3
Application*: E, F, IH, P, WB
Target: GJB2
Host: Mouse
Antibody Isotype: IgG2b
Specificity: Human
Clone: 13B447
Application*: E, F, IH, WB
More Infomation
Hot products 
-
Mouse Anti-EPO Recombinant Antibody (CBFYR0196) (CBMAB-R0196-FY)
-
Mouse Anti-BMI1 Recombinant Antibody (CBYC-P026) (CBMAB-P0108-YC)
-
Mouse Anti-NSUN6 Recombinant Antibody (D-5) (CBMAB-N3674-WJ)
-
Mouse Anti-ARG1 Recombinant Antibody (CBYCL-103) (CBMAB-L0004-YC)
-
Mouse Anti-ABCA3 Recombinant Antibody (V2-178911) (CBMAB-A0145-YC)
-
Mouse Anti-AOC3 Recombinant Antibody (CBYY-0014) (CBMAB-0014-YY)
-
Mouse Anti-CEMIP Recombinant Antibody (3C12) (CBMAB-K0296-LY)
-
Mouse Anti-CCL18 Recombinant Antibody (64507) (CBMAB-C7910-LY)
-
Mouse Anti-14-3-3 Pan Recombinant Antibody (V2-9272) (CBMAB-1181-LY)
-
Mouse Anti-ACLY Recombinant Antibody (V2-179314) (CBMAB-A0610-YC)
-
Rabbit Anti-ADRA1A Recombinant Antibody (V2-12532) (CBMAB-1022-CN)
-
Mouse Anti-CD24 Recombinant Antibody (SN3) (CBMAB-C1037-CQ)
-
Mouse Anti-ABL2 Recombinant Antibody (V2-179121) (CBMAB-A0364-YC)
-
Mouse Anti-ADRB2 Recombinant Antibody (V2-180026) (CBMAB-A1420-YC)
-
Rabbit Anti-CCN1 Recombinant Antibody (CBWJC-3580) (CBMAB-C4816WJ)
-
Mouse Anti-COL1A2 Recombinant Antibody (CF108) (V2LY-1206-LY626)
-
Mouse Anti-ADGRE5 Recombinant Antibody (V2-360335) (CBMAB-C2088-CQ)
-
Mouse Anti-DMPK Recombinant Antibody (CBYCD-324) (CBMAB-D1200-YC)
-
Mouse Anti-ENO1 Recombinant Antibody (CBYC-A950) (CBMAB-A4388-YC)
-
Mouse Anti-CFL1 (Phospho-Ser3) Recombinant Antibody (CBFYC-1770) (CBMAB-C1832-FY)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
Online Inquiry




